CS logo
small CS logo
Sacred Heart Hospital

Allentown, Pennsylvania, United States
Hospital in Allentown, Pennsylvania
421 W Chew St, Allentown, PA 18102

About Sacred Heart Hospital


"St. Luke’s Sacred Heart Campus features advanced inpatient and outpatient services along with specialty services in the Hospital, Medical Office Building and at the Sigal Center for Family Medicine. Patients benefit from emergency room services, surgical services, behavioral health services, radiology & lab services and more."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Sacred Heart Hospital


During the past decade, Sacred Heart Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Sacred Heart Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 3 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "Organogenesis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sacred Heart Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "American College of Surgeons" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Sacred Heart Hospital


According to Clinical.Site data, the most researched conditions in "Sacred Heart Hospital" are "Breast Cancer" (6 trials), "Angina Pectoris" (1 trials), "Breast Adenocarcinoma" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials) and "Chronic Vascular Ulcer" (1 trials). Many other conditions were trialed in "Sacred Heart Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Sacred Heart Hospital


Most popular intervention types in "Sacred Heart Hospital" are "Drug" (6 trials), "Other" (5 trials), "Radiation" (5 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Letrozole" (2 trials), "Radiation Therapy" (2 trials), "axillary lymph node dissection" (2 trials) and "sentinel lymph node biopsy" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Sacred Heart Hospital


The vast majority of trials in "Sacred Heart Hospital" are 8 trials for "Female" genders and 3 trials for "All" genders.

Clinical Trials Status at Sacred Heart Hospital


Currently, there are NaN active trials in "Sacred Heart Hospital". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sacred Heart Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sacred Heart Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status